celecoxib, naproxen + esomeprazole, acetaminophen + tramadol, oxycodone + naloxone

This combination describes a **list of four pharmaceutical products**, three of which are **combination drugs**: - **Celecoxib** is a selective COX-2 inhibitor (NSAID) for pain and inflammation, particularly in arthritis. - **Naproxen + esomeprazole** is a fixed-dose combination used primarily for arthritis. Naproxen is a nonselective NSAID, and esomeprazole is a proton pump inhibitor (PPI) included to reduce stomach acid and lower the risk of ulcers related to NSAID use. This combination is marketed as Vimovo and is indicated for osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, especially in patients at risk for gastric ulcers[1][3][5][9]. - **Acetaminophen + tramadol** is a combination analgesic used for short-term treatment of moderate-to-severe acute pain. Tramadol is a centrally acting opioid receptor agonist with weak opioid activity, and acetaminophen is a non-opioid analgesic. The combination is intended to provide synergistic pain relief with lower doses of each component, potentially reducing the risk of side effects[2][4][6][8][10]. - **Oxycodone + naloxone** is an opioid analgesic/narcotic antagonist combination. Oxycodone is a potent opioid agonist, and naloxone is included to reduce opioid-induced constipation and deter abuse via non-oral routes. This combination is used for chronic severe pain requiring long-term opioid treatment and where alternative options are inadequate.

Brand names

CelebrexVimovoUltracetTramacetTarginTarginiq ER